Clinical Trial Update: Phase 4 Gastrointestinal Tolerability Study of Dimethyl Fumarate in Patients With Relapsing Forms of Multiple Sclerosis in the United States [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the gastrointestinal tolerability of dimethyl fumarate in adults with relapsing forms of multiple sclerosis; results were posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing Forms of Multiple Sclerosis

Drugs mentioned

• Tecfidera (dimethyl fumarate)

Snippet

Sponsor: Biogen | Conditions: Relapsing Forms of Multiple Sclerosis | Phase 4 | Status: COMPLETED | Results posted: 2014-11-11